Basic Information
LncRNA/CircRNA Name | LINC00857 |
Synonyms | NA |
Region | GRCh38_10:80207710-80219657 |
Ensemble | ENSG00000237523 |
Refseq | NR_038464 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | gastric cancer |
ICD-0-3 | C16 |
Methods | Microarray, qPCR, Western blot, Luciferase reporter assay |
Sample | gastric cancer tissues, cell lines (AGS, BGC-823, MKN-45,SGC-7901 and GES-1) |
Expression Pattern | up-regulated |
Function Description | The results of the present study demonstrate that an lncRNA, LINC00857, was increased in GC tissues compared with adjacent non-tumor tissues. Overexpression of LINC00857 was positively associated with poor survival rate, as well as with the tumor size of patients with GC. LINC00857 knockdown induced by specific small interfering RNAs significantly inhibited GC cell proliferation in vitro. Genome-wide analysis revealed that LINC00857 knockdown deregulated the cell cycle. Western blot analysis confirmed that LINC00857 knockdown decreased protein expression of cyclin D1 and cyclin E1 in GC cells. Taken together, the results indicated that LINC00857 knockdown suppressed GC cell proliferation through deregulating the cell cycle, resulting in the downregulation of cyclin D1 and cyclin E1. |
Pubmed ID | 30008909 |
Year | 2018 |
Title | Long Non-Coding RNA LINC00857 Promotes Gastric Cancer Cell Proliferation and Predicts Poor Patient Survival |
External Links
Links for LINC00857 | GenBank HGNC NONCODE |
Links for gastric cancer | OMIM COSMIC |